Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
114,331,829
-
Total 13F shares
-
18,614,016
-
Share change
-
+242,939
-
Total reported value
-
$62,724,000
-
Price per share
-
$3.37
-
Number of holders
-
51
-
Value change
-
-$726,308
-
Number of buys
-
30
-
Number of sells
-
13
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q4 2015
As of 31 Dec 2015,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,614,016 shares.
The largest 10 holders included
FMR LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., Polaris Venture Management Co. V, L.L.C., Redmile Group, LLC, WELLINGTON MANAGEMENT GROUP LLP, Broadfin Capital, LLC, ORBIMED ADVISORS LLC, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, and PRINCIPAL FINANCIAL GROUP INC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.